Business
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead
MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange Admission follows successful IPO for $11.6m from sophisticated and…
Link copied toclipboard
- MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
- Admission follows successful IPO for $11.6m from sophisticated and institutional investors
- Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors
The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…
Continue Reading
-
General24 hours agoMan dies in daylight shooting in Sydney’s north-west
-
General17 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General13 hours agoRenters surprise winners from cheaper mortgage deposits
-
General23 hours agoWomen’s Cricket World Cup live: Australia vs Pakistan scores, stats, results and commentary